Complicated Urinary Tract Infection Clinical Trial
Official title:
Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions. Impact of the CMI and Baseline Mutations. FOSFO-MIC Project
This will be a prospective observational multicentre study in real-life conditions of
patients with complicated urinary infection of community presentation caused by Escherichia
coli using intravenous fosfomycin, quinolones or beta-lactams.
It's a multicenter and multinational study and it will include 200 patients in the fosfomycin
cohort and 200 patients in the control cohort (quinolones or beta-lactams).
The objectives are:
1. To asses the clinical and microbiological efficacy and safety of intravenous fosfomycin
in the treatment of complicated urinary tract infections due to Escherichia coli in real
life conditions, in comparison with a matched cohort of patients treated with quinolones
or beta-lactams.
2. To evaluate the frequency of microbiological failure and development of resistance (or
decrease in sensitivity) in Escherichia coli isolates, depending on different
pharmacokinetic and pharmacodynamic parameters, with special emphasis on fAUC0-24/MIC.
3. To evaluate the frequency of microbiological failure and development of resistance (or
decrease in sensitivity) and their association with the existence of basal mutations in
genes related to intracellular transport or regulation of these transporters.
For objective 1, a study of prospective mated cohorts (fosfomycin cohort versus quinolones or
beta-lactams cohort) will be performed, and for objectives 2 and 3 a prospective cohort study
(fosfomycin cohort) will be conducted.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05905055 -
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
|
Phase 3 | |
| Recruiting |
NCT05826990 -
A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
|
Phase 2 | |
| Not yet recruiting |
NCT05060419 -
Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections
|
Phase 2 | |
| Completed |
NCT03293485 -
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)
|
Phase 3 | |
| Completed |
NCT00690378 -
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
|
Phase 2 | |
| Recruiting |
NCT04876131 -
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
|
Phase 4 | |
| Recruiting |
NCT05887908 -
Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
|
Phase 3 | |
| Completed |
NCT00921024 -
Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections
|
Phase 2 | |
| Completed |
NCT03788967 -
Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
|
Phase 3 | |
| Recruiting |
NCT05674032 -
Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
|
||
| Completed |
NCT01345929 -
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
|
Phase 3 | |
| Completed |
NCT05385536 -
Evaluating UTI Outcomes in at Risk Populations
|
||
| Completed |
NCT01096849 -
A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)
|
Phase 2 | |
| Not yet recruiting |
NCT03630081 -
Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
|
Phase 3 | |
| Completed |
NCT02024282 -
Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care
|
N/A | |
| Completed |
NCT01644643 -
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
|
Phase 3 | |
| Completed |
NCT03445195 -
Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections
|
Phase 2 | |
| Completed |
NCT02486627 -
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
|
Phase 3 | |
| Recruiting |
NCT05733104 -
A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
|
||
| Recruiting |
NCT04979806 -
Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
|
Phase 3 |